Shivalik Rasayan Ltd
- Market Cap ₹ 970 Cr.
- Current Price ₹ 669
- High / Low ₹ 1,107 / 656
- Stock P/E 51.3
- Book Value ₹ 194
- Dividend Yield 0.07 %
- ROCE 8.50 %
- ROE 8.73 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 42.5% CAGR over last 5 years
- Debtor days have improved from 48.1 to 24.9 days.
Cons
- Stock is trading at 3.45 times its book value
- Tax rate seems low
- Company has a low return on equity of 7.29% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
25 | 26 | 29 | 35 | 41 | 43 | 41 | 44 | 48 | 61 | 85 | 99 | 100 | |
24 | 24 | 27 | 33 | 38 | 38 | 34 | 36 | 42 | 51 | 66 | 76 | 78 | |
Operating Profit | 1 | 1 | 2 | 2 | 3 | 5 | 7 | 7 | 6 | 9 | 19 | 23 | 22 |
OPM % | 3% | 6% | 5% | 6% | 7% | 11% | 17% | 17% | 13% | 16% | 22% | 23% | 22% |
0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 4 | 1 | 0 | 2 | 3 | |
Interest | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 6 | 5 | 5 |
Profit before tax | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 6 | 9 | 9 | 13 | 19 | 19 |
Tax % | 31% | 31% | 32% | 34% | 33% | 33% | 33% | 19% | -3% | -0% | -1% | -3% | |
Net Profit | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 9 | 9 | 13 | 19 | 19 |
EPS in Rs | 0.71 | 1.01 | 1.08 | 1.37 | 2.10 | 3.10 | 3.84 | 4.84 | 6.47 | 6.35 | 9.20 | 13.36 | 13.05 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 8% | 8% | 4% | 5% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 19% |
3 Years: | 27% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 36% |
5 Years: | 42% |
3 Years: | 30% |
TTM: | 3% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 38% |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 8% |
3 Years: | 7% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 7 | 7 | 7 | 7 | 7 | |
Reserves | 3 | 4 | 5 | 6 | 8 | 10 | 14 | 42 | 153 | 161 | 173 | 256 | 274 |
0 | 2 | 0 | 0 | 0 | 11 | 14 | 8 | 9 | 0 | 11 | 15 | 18 | |
4 | 6 | 8 | 9 | 11 | 12 | 7 | 7 | 10 | 18 | 31 | 39 | 26 | |
Total Liabilities | 10 | 15 | 16 | 18 | 23 | 37 | 38 | 61 | 178 | 186 | 223 | 318 | 326 |
2 | 6 | 7 | 6 | 7 | 8 | 8 | 15 | 16 | 18 | 120 | 128 | 126 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 61 | 0 | 3 | 11 |
Investments | 0 | 0 | 0 | 0 | 0 | 16 | 18 | 27 | 27 | 39 | 53 | 55 | 65 |
8 | 9 | 10 | 12 | 16 | 13 | 12 | 19 | 124 | 68 | 49 | 131 | 123 | |
Total Assets | 10 | 15 | 16 | 18 | 23 | 37 | 38 | 61 | 178 | 186 | 223 | 318 | 326 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | 6 | -3 | -1 | 4 | 6 | 4 | -2 | -12 | -7 | 46 | 7 | |
-0 | -4 | 0 | 0 | -0 | -17 | -2 | -16 | -9 | -65 | -61 | -16 | |
0 | -3 | 3 | 0 | 1 | 7 | -2 | 19 | 104 | -9 | 10 | 76 | |
Net Cash Flow | -1 | -1 | -0 | -0 | 4 | -4 | 1 | 2 | 83 | -81 | -5 | 66 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 79 | 78 | 76 | 93 | 80 | 61 | 47 | 64 | 66 | 49 | 70 | 25 |
Inventory Days | 18 | 42 | 32 | 8 | 5 | 14 | 22 | 36 | 82 | 33 | 45 | 97 |
Days Payable | 54 | 72 | 112 | 103 | 126 | 139 | 76 | 66 | 92 | 166 | 119 | 108 |
Cash Conversion Cycle | 42 | 48 | -4 | -2 | -41 | -64 | -8 | 34 | 56 | -83 | -4 | 14 |
Working Capital Days | 49 | 40 | 4 | 17 | -11 | -40 | -37 | 38 | 169 | 202 | 33 | 86 |
ROCE % | 14% | 20% | 19% | 23% | 29% | 28% | 25% | 18% | 9% | 6% | 7% | 8% |
Documents
Announcements
- Board Meeting Intimation for Consider, Approve And Take On Record Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended On December 31, 2022 31 Jan
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2022
-
Annual Communique-2023
31 Dec 2022 - Communique-2023' of the Company sent through email to the shareholders of the Company.
- Closure of Trading Window 30 Dec 2022
- Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulations, 2015 21 Nov 2022
Business Segments
Shivalik Rasayan is into 2 business segments :
1. Agrochemicals: Largest producer of Dimethoate Technical and second largest producer of Malathion Technical in India.
2. API: The Company has commenced new pharma API manufacturing facility at PCPIR (Petroleum, Chemicals and Petrochemicals Investment Region) zone in Dahej (Gujarat) which is US FDA and EU standard compliant and provides one stop solution for direct commercial production, R&D, pilot scale batches, Contract Manufacturing (CMO) and Contract Research (CRO) services.[1]